-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Market Analysis] Traditional Chinese medicine has unique advantages in disease prevention, treatment and rehabilitation
.
In recent years, in order to vigorously develop the traditional Chinese medicine industry, the state has been accelerating the reform, innovation and development of the traditional Chinese medicine industry
.
Affected by this, favorable policies for traditional Chinese medicine have also begun to be released in a concentrated manner
.
For example, in February 2016, the State Council issued the "Outline of the Strategic Plan for the Development of Traditional Chinese Medicine (2016-2030)", which laid the general tone for supporting the development of traditional Chinese medicine.
Elevate the development of traditional Chinese medicine to a national strategy
.
Among them, it is worth mentioning that the "14th Five-Year Plan for National Drug Safety and Promotion of High-Quality Development" jointly issued by the State Drug Administration and other 8 departments earlier clearly proposed that new steps should be taken in the inheritance, innovation and development of traditional Chinese medicine.
, The evaluation evidence system combining traditional Chinese medicine theory, human experience and clinical trials is initially established, and the goal of gradually exploring the establishment of safety evaluation methods and standard systems that meet the characteristics of traditional Chinese medicine, and making the modern supervision system of traditional Chinese medicine more perfect
.
The industry believes that the development of the traditional Chinese medicine industry has become a long-term plan for the country and even all regions
.
In the future, under the background of continuous favorable policies, the traditional Chinese medicine industry will also usher in continuous favorable conditions
.
At present, many institutions are optimistic about the future development space of the traditional Chinese medicine industry
.
Among them, some institutions believe that under the careful care of policies, the traditional Chinese medicine industry is expected to usher in a new life
.
It is recommended to pay attention to the two sub-tracks of traditional Chinese medicine formula granules and traditional Chinese medicine innovative drugs, and be optimistic about the giants of traditional Chinese medicine formula granules with integrated and scale advantages, such as Hongri Pharmaceutical, China Resources Sanjiu, etc.
; as well as the giants of traditional Chinese medicine innovative drugs with outstanding research and development capabilities , such as Yiling Pharmaceutical and so on
.
In addition to the TCM formula granules and the innovative TCM drug track, the industry believes that the market prospects for TCM health services are also very promising.
.
It is suggested that relevant enterprises can increase their layout in this field
.
In addition to the above areas, because OTC of traditional Chinese medicine has no risk of centralized procurement, and the out-of-hospital market has independent pricing power, it helps the product to maintain a high profit margin
.
It is suggested in the industry to focus on two types of enterprises, one is the target with exclusive varieties and confidential varieties, and has high intellectual property barriers, such as Tong Ren Tang, Pien Tze Huang, Jianmin Group,
etc.
The second is the target with omni-channel coverage and brand strength, such as China Resources Sanjiu, Taiji Group, Lingrui Pharmaceutical,
etc.
However, although the industry generally believes that the traditional Chinese medicine industry will gain further benefits, a large number of pharmaceutical companies will benefit
.
However, it should be noted that with the rapid development of the traditional Chinese medicine industry, analysts also pointed out that there are still many challenges to strengthen traditional Chinese medicine, such as the shortage of high-level talents in traditional Chinese medicine, the low level of scientific and technological research and development, the imperfect service system, and the lack of traditional Chinese medicine.
Insufficient cultural development,
etc.
Therefore, for traditional Chinese medicine enterprises, it is necessary to continue to inherit the essence, keep upright and innovate, to meet a larger market development space, and to move towards a higher-quality development path
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
In recent years, in order to vigorously develop the traditional Chinese medicine industry, the state has been accelerating the reform, innovation and development of the traditional Chinese medicine industry
.
Affected by this, favorable policies for traditional Chinese medicine have also begun to be released in a concentrated manner
.
For example, in February 2016, the State Council issued the "Outline of the Strategic Plan for the Development of Traditional Chinese Medicine (2016-2030)", which laid the general tone for supporting the development of traditional Chinese medicine.
Elevate the development of traditional Chinese medicine to a national strategy
.
Among them, it is worth mentioning that the "14th Five-Year Plan for National Drug Safety and Promotion of High-Quality Development" jointly issued by the State Drug Administration and other 8 departments earlier clearly proposed that new steps should be taken in the inheritance, innovation and development of traditional Chinese medicine.
, The evaluation evidence system combining traditional Chinese medicine theory, human experience and clinical trials is initially established, and the goal of gradually exploring the establishment of safety evaluation methods and standard systems that meet the characteristics of traditional Chinese medicine, and making the modern supervision system of traditional Chinese medicine more perfect
.
The industry believes that the development of the traditional Chinese medicine industry has become a long-term plan for the country and even all regions
.
In the future, under the background of continuous favorable policies, the traditional Chinese medicine industry will also usher in continuous favorable conditions
.
At present, many institutions are optimistic about the future development space of the traditional Chinese medicine industry
.
Among them, some institutions believe that under the careful care of policies, the traditional Chinese medicine industry is expected to usher in a new life
.
It is recommended to pay attention to the two sub-tracks of traditional Chinese medicine formula granules and traditional Chinese medicine innovative drugs, and be optimistic about the giants of traditional Chinese medicine formula granules with integrated and scale advantages, such as Hongri Pharmaceutical, China Resources Sanjiu, etc.
; as well as the giants of traditional Chinese medicine innovative drugs with outstanding research and development capabilities , such as Yiling Pharmaceutical and so on
.
In addition to the TCM formula granules and the innovative TCM drug track, the industry believes that the market prospects for TCM health services are also very promising.
.
It is suggested that relevant enterprises can increase their layout in this field
.
In addition to the above areas, because OTC of traditional Chinese medicine has no risk of centralized procurement, and the out-of-hospital market has independent pricing power, it helps the product to maintain a high profit margin
.
It is suggested in the industry to focus on two types of enterprises, one is the target with exclusive varieties and confidential varieties, and has high intellectual property barriers, such as Tong Ren Tang, Pien Tze Huang, Jianmin Group,
etc.
The second is the target with omni-channel coverage and brand strength, such as China Resources Sanjiu, Taiji Group, Lingrui Pharmaceutical,
etc.
However, although the industry generally believes that the traditional Chinese medicine industry will gain further benefits, a large number of pharmaceutical companies will benefit
.
However, it should be noted that with the rapid development of the traditional Chinese medicine industry, analysts also pointed out that there are still many challenges to strengthen traditional Chinese medicine, such as the shortage of high-level talents in traditional Chinese medicine, the low level of scientific and technological research and development, the imperfect service system, and the lack of traditional Chinese medicine.
Insufficient cultural development,
etc.
Therefore, for traditional Chinese medicine enterprises, it is necessary to continue to inherit the essence, keep upright and innovate, to meet a larger market development space, and to move towards a higher-quality development path
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
